Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Cappelletti

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
British Journal of Cancer|April 13, 2013
Increased pathological complete response rate after a long-term neoadjuvant letrozole treatment in postmenopausal oestrogen and/or progesterone receptor-positive breast cancerG Allevi, C Strina, D Andreis, et al.
Breast (Edinburgh, Scotland)|May 4, 2019
Efficacy of extended aromatase inhibitors for hormone-receptor-positive breast cancer: A literature-based meta-analysis of randomized trialsS P Corona, G Roviello, C Strina, et al.
British Journal of Cancer|December 3, 2014
Combination of letrozole, metronomic cyclophosphamide and sorafenib is well-tolerated and shows activity in patients with primary breast cancerL Bazzola, C Foroni, D Andreis, et al.
Viruses|November 24, 2022
Epidemiological and Clinical Features of SARS-CoV-2 Variants Circulating between April-December 2021 in ItalyAlessia Lai, Annalisa Bergna, Carla Della Ventura, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
British Journal of Cancer|April 13, 2013
Increased pathological complete response rate after a long-term neoadjuvant letrozole treatment in postmenopausal oestrogen and/or progesterone receptor-positive breast cancerG Allevi, C Strina, D Andreis, et al.
Breast (Edinburgh, Scotland)|May 4, 2019
Efficacy of extended aromatase inhibitors for hormone-receptor-positive breast cancer: A literature-based meta-analysis of randomized trialsS P Corona, G Roviello, C Strina, et al.
British Journal of Cancer|December 3, 2014
Combination of letrozole, metronomic cyclophosphamide and sorafenib is well-tolerated and shows activity in patients with primary breast cancerL Bazzola, C Foroni, D Andreis, et al.
Viruses|November 24, 2022
Epidemiological and Clinical Features of SARS-CoV-2 Variants Circulating between April-December 2021 in ItalyAlessia Lai, Annalisa Bergna, Carla Della Ventura, et al.
Pageof 5